FDA clears Siemens angiography systems

The Artis Q and Artis Q.zen angiography system families from Siemens Healthcare have been cleared by the FDA.

Siemens uses second-generation flat emitter technology in the Artis Q and Artis Q.zen x-ray tubes, rather than a coiled filament. This is designed to improve the ability to identify small vessels, according to the company.

The systems’ detector technology was updated to utilize doses as low as half the standard levels applied angiography, according to Siemens.

New applications allow for the integration of intravascular ultrasound in the treatment of coronary artery disease, and CLEARstent Live is an application allowing cardiologists to image stents with motion stabilization in real time. Other 3D applications have been designed to image small structures in the head, such as the cochlea.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup